Commission's Go-Live Date For New Eudamed Medical Device Database: Will It Actually Be Met?

Many questions surrounding compliance with the data submission requirements under the new Eudamed database remain outstanding. How should companies plan their submissions in the face of these uncertainties? And will the database even be ready on time, or will it be subject to a delay of up to six months?

MT1807_Clock-Hands_8128456_1200.jpg

There is hopeful news for the EU medical technology sector in terms of preparing for timely compliance with the database elements of the new EU medical device regulations. There have been repeated messages over the last few weeks that the go-live target date for the new version of Eudamed, the European medical device database, is March 26, 2020 – two months before the date of the full application of the new Medical Devices Regulation (MDR), and very much in line with what was being promised a couple of years ago. But there is also a degree of skepticism over whether this will actually happen on time.

Manufacturers all need to be alive to the database's development requirements. As delegates heard at the Association of British HealthTech...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By 

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By 

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

More from Geography